Potential of PI3Kβ Inhibitors in the Treatment of Cancer and Other Diseases

ADVERTISEMENT RETURN TO ISSUEPREVPatent HighlightNEXTPotential of PI3Kβ Inhibitors in the Treatment of Cancer and Other DiseasesAhmed F. Abdel-Magid*View Author Information Therachem Research Medilab (India) Pvt. Ltd., Jaipur, India*Address: 1383 Jasper Drive, Ambler, Pennsylvania 19002, United States. Tel: 215-913-7202. E-mail: [email protected]Cite this: ACS Med. Chem. Lett. 2017, 8, 8, 778–780Publication Date (Web):July 6, 2017Publication History Received26 June 2017Published online6 July 2017Published inissue 10 August 2017https://pubs.acs.org/doi/10.1021/acsmedchemlett.7b00254https://doi.org/10.1021/acsmedchemlett.7b00254editorialACS PublicationsCopyright © 2017 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views1114Altmetric-Citations2LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (429 KB) Get e-AlertscloseSUBJECTS:Assays,Cancer,Inhibitors,Lipids,Peptides and proteins Get e-Alerts